Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy

ConclusionsWe could not confirm previous findings of a higher risk of malabsorption in olmesartan‐only patients, and drug‐induced enteropathy should be considered the result of exposure to the class of ARBs rather than a specific drug‐related effect.

Source: Pharmacoepidemiology and Drug Safety - February 1, 2018 Category: Drugs & Pharmacology Authors: Peter Malfertheiner, Claudio Ripellino, Nazarena Cataldo Tags: ORIGINAL REPORT Source Type: research